asacard 162.5 mg prolonged release hard capsules
new haven pharma (uk) limited - acetylsalicylic acid - prolonged-release capsule, hard - 162.5 milligram(s) - platelet aggregation inhibitors excl. heparin; acetylsalicylic acid
aspirin rowex 75mg gastro-resistant tablets
rowex ltd - acetylsalicylic acid - gastro-resistant tablet - 75 milligram(s) - platelet aggregation inhibitors excl. heparin; acetylsalicylic acid - antithrombotic agents: platelet aggregation inhibitors excl. heparin - it is used for: secondary prevention of myocardial infarction, prevention of cardiovascular morbidity in patients suffering from stable angina pectoris, history of unstable angina pectoris, except during the acute phase, prevention of graft occlusion after coronary artery bypass grafting (cabg), coronary angioplasty, except during the acute phase, secondary prevention of transient ischaemic attacks (tia) and ischaemic cerebrovascular accidents (cva), provided intracerebral haemorrhages have been ruled out.
anadin extra film-coated tabletsaspirin 300mgparacetamol 200mgcaffeine 45mg
pfizer healthcare ireland - acetylsalicylic acid; caffeine; paracetamol - film-coated tablet - 300/200/45 milligram(s) - salicylic acid and derivatives; acetylsalicylic acid, combinations excl. psycholeptics
aspirine-c efferv. tabl.
bayer sa-nv - acetylsalicylic acid 400 mg - effervescent tablet - 400 mg - 240 mg - acetylsalicylic acid 400 mg; ascorbic acid 240 mg - acetylsalicylic acid, combinations excl. psycholeptics
aspirin 75mg gastro-resistant tablets caprin 75mg gastro-resistant tablets
wockhardt uk limited - acetylsalicylic acid - gastro-resistant tablet - acetylsalicylic acid 75 mg - antithrombotic agents
aspirin 75mg gastro-resistant tablets
pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - acetylsalicylic acid - gastro-resistant tablet - acetylsalicylic acid 75 mg - antithrombotic agents
ibandronic acid teva
teva pharma b.v. - ibandronic acid - breast neoplasms; neoplasm metastasis; fractures, bone; osteoporosis, postmenopausal - drugs for treatment of bone diseases - ibandronic acid 50mgibandronic acid teva is indicated for the prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.ibandronic acid 150mgtreatment of osteoporosis in postmenopausal women at increased risk of fracture. a reduction in the risk of vertebral fractures has been demonstrated, efficacy on femoral neck fractures has not been established.
excedrin
gsk consumer healthcare, israel ltd - acetylsalicylic acid; caffeine; paracetamol - caplets - paracetamol 250 mg; acetylsalicylic acid 250 mg; caffeine 65 mg - paracetamol, combinations excl. psycholeptics - paracetamol, combinations excl. psycholeptics - for temporary relief of the pain of headache, mild to moderate pain associated with migraine headache, pain of menstrual descomfort and pain accompanied by fever.
excedrin
gsk consumer healthcare, israel ltd - acetylsalicylic acid; caffeine; paracetamol - caplets - paracetamol 250 mg; acetylsalicylic acid 250 mg; caffeine 65 mg - paracetamol, combinations excl. psycholeptics - for temporary relief of the pain of headache, mild to moderate pain associated with migraine headache, pain of menstrual descomfort and pain accompanied by fever.
salicylic acid- salicylic acid lotion
nationwide laboratories, llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 6 g in 100 ml - for dermatologic use: salicylic acid 6% is a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders including verrucae, and the various ichthyoses (vulgaris, sex-linked and lamellar), keratosis palmaris and plantaris keratosis pilaris, pityriasis rubra pilaris, and psoriasis (including body, scalp, palms and soles). for podiatric use: salicylic acid 6% is a topical aid in the removal of excessive keratin on dorsal and plantar hyperkeratotic lesions. topical preparations of 6% salicylic acid have been reported to be useful adjunctive therapy for verrucae plantares. salicylic acid 6% should not be used in any patient known to be sensitive to salicylic acid or any other listed ingredients. salicylic acid 6% should not be used in children under 2 years of age.